It is now acknowledged that changes in the AD brain occur decades before clinical symptomology, where prodromal cellular alterations occurring before the accumulation of Aβ plaques and aberrant tau initiate a cascade of events, likely in a synergistic manner, that ultimately culminate in the neurodegeneration underlying cognitive deficits. Here, MAPT is linked to Alzheimer disease.